Abstract
Because the majority of small renal masses (SRMs; <4 cm) demonstrate low metastatic potential and can be effectively treated with radical or partial nephrectomy, the role of lymph node dissection (LND) at the time of surgery is unclear. A randomized trial demonstrated no survival benefit of LND in clinically localized renal cell carcinoma. Thus, LND is not recommended routinely for SRMs. For patients with high-risk features or radiographic evidence of lymphadenopathy, however, LND may improve local staging and potentially provide a survival benefit. If performed, a LND template should be based on the known lymphatic drainage of the kidneys.
Original language | English (US) |
---|---|
Pages (from-to) | 269-274 |
Number of pages | 6 |
Journal | Urologic Clinics of North America |
Volume | 44 |
Issue number | 2 |
DOIs | |
State | Published - May 1 2017 |
Externally published | Yes |
Keywords
- Lymph node dissection (LND)
- Renal cell carcinoma (RCC)
- Small renal mass (SRM)
ASJC Scopus subject areas
- Urology